Pharma industry insists European drugs are affordable

The European pharma industry has commissioned a  report on drug affordability which highlights its message that overall expenditure on therapies has remained stable.

Written by industry analyst IQVIA, the document includes estimates of total pharmaceutical spending for the past two decades, including hospital spending, taking into account discounts and rebates.

The researchers found that, in all of the 15 countries studied, spending on pharmaceuticals represents a fairly small proportion of overall spending, around 15%.